Drug Target Discovery Team

Dr Spiros Linardopoulos's laboratory aims to identify and validate new molecular targets and to develop drugs through the process of hit generation, lead identification/optimisation and candidate selection.  It also aims to identify tumour types and patient subgroups that would benefit from specific treatments. Dr Linardopoulos's programme encompasses both basic research and drug discovery components.